✦ LIBER ✦

Cost-effectiveness of warfarin: Trial versus “real-world” stroke prevention in atrial fibrillation

✍ Scribed by Sonja V. Sorensen; Sarah Dewilde; Daniel E. Singer; Samuel Z. Goldhaber; Brigitta U. Monz; Jonathan M. Plumb

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost–Effectiveness of Rivaroxaban Compar

✍ Soyon Lee; Moise W. Anglade; Dan Pham; Robyn Pisacane; Jeffrey Kluger; Craig I. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 786 KB

Cost-effectiveness of apixaban vs warfar

✍ Kamel, H.; Easton, J. D.; Johnston, S. C.; Kim, A. S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 578 KB

PCV57 Cost-Effectiveness of Rivaroxaban

✍ A.K. Kapur; I. Chatzitheofilou; L.K. Schang 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Warfarin versus aspirin for prevention o

✍ Stroke Prevention in Atrial Fibrillation Investigators 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 686 KB

COST-EFFECTIVENESS OF RIVAROXABAN COMPAR

✍ Soyon Lee; Moise Anglade; Robyn Pisacane; Dan Pham; Jeffrey Kluger; Craig Colema 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 89 KB

PCV50 COST-EFFECTIVENESS ANALYSIS COMPAR

✍ Y. Zhao; L. Lim; C.I. Coleman 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB